A Single-Arm Exploratory Study to Evaluate the Efficacy and Safety of Recombinant Fully Human Anti-IL-17A Monoclonal Antibody Injection (GR1501) in the Treatment of Refractory Gout (ChiCTR) - Jul 23, 2026 - P=N/A | N=15 | Not yet recruiting | Sponsor: Affiliated Hospital of North Sichuan Medical College; Affiliated Hospital of North Sichuan Medical College
New trial • Gout • Inflammatory Arthritis • Rheumatology
|